vs

Side-by-side financial comparison of ILLUMINA, INC. (ILMN) and STIFEL FINANCIAL CORP (SF). Click either name above to swap in a different company.

STIFEL FINANCIAL CORP is the larger business by last-quarter revenue ($1.1B vs $1.1B, roughly 1.0× ILLUMINA, INC.). STIFEL FINANCIAL CORP runs the higher net margin — 23.5% vs 12.3%, a 11.2% gap on every dollar of revenue. On growth, STIFEL FINANCIAL CORP posted the faster year-over-year revenue change (23.0% vs 4.8%). STIFEL FINANCIAL CORP produced more free cash flow last quarter ($369.0M vs $251.0M). Over the past eight quarters, STIFEL FINANCIAL CORP's revenue compounded faster (21.1% CAGR vs -1.3%).

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

Stifel Financial Corp. is an American multinational independent investment bank and financial services company created under the Stifel name in July 1983 and listed on the New York Stock Exchange on November 24, 1986. Its predecessor company was founded in 1890 as the Altheimer and Rawlings Investment Company and is headquartered in downtown St. Louis, Missouri.

ILMN vs SF — Head-to-Head

Bigger by revenue
SF
SF
1.0× larger
SF
$1.1B
$1.1B
ILMN
Growing faster (revenue YoY)
SF
SF
+18.2% gap
SF
23.0%
4.8%
ILMN
Higher net margin
SF
SF
11.2% more per $
SF
23.5%
12.3%
ILMN
More free cash flow
SF
SF
$118.0M more FCF
SF
$369.0M
$251.0M
ILMN
Faster 2-yr revenue CAGR
SF
SF
Annualised
SF
21.1%
-1.3%
ILMN

Income Statement — Q1 FY2027 vs Q4 FY2025

Metric
ILMN
ILMN
SF
SF
Revenue
$1.1B
$1.1B
Net Profit
$134.0M
$264.4M
Gross Margin
66.1%
Operating Margin
19.2%
27.3%
Net Margin
12.3%
23.5%
Revenue YoY
4.8%
23.0%
Net Profit YoY
8.3%
EPS (diluted)
$0.87
$2.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILMN
ILMN
SF
SF
Q1 26
$1.1B
Q4 25
$1.2B
$1.1B
Q3 25
$962.6M
Q2 25
$838.9M
Q1 25
$842.5M
Q4 24
$1.1B
$916.0M
Q3 24
$1.1B
$810.9M
Q2 24
$1.1B
$798.9M
Net Profit
ILMN
ILMN
SF
SF
Q1 26
$134.0M
Q4 25
$334.0M
$264.4M
Q3 25
$211.4M
Q2 25
$155.1M
Q1 25
$53.0M
Q4 24
$186.0M
$244.0M
Q3 24
$705.0M
$158.5M
Q2 24
$-2.0B
$165.3M
Gross Margin
ILMN
ILMN
SF
SF
Q1 26
66.1%
Q4 25
65.5%
Q3 25
Q2 25
Q1 25
Q4 24
65.9%
Q3 24
69.0%
Q2 24
64.8%
Operating Margin
ILMN
ILMN
SF
SF
Q1 26
19.2%
Q4 25
17.4%
27.3%
Q3 25
29.7%
Q2 25
25.5%
Q1 25
7.5%
Q4 24
15.8%
29.1%
Q3 24
68.6%
26.7%
Q2 24
-147.2%
28.4%
Net Margin
ILMN
ILMN
SF
SF
Q1 26
12.3%
Q4 25
28.8%
23.5%
Q3 25
22.0%
Q2 25
18.5%
Q1 25
6.3%
Q4 24
16.8%
26.6%
Q3 24
65.3%
19.5%
Q2 24
-178.8%
20.7%
EPS (diluted)
ILMN
ILMN
SF
SF
Q1 26
$0.87
Q4 25
$2.16
$2.30
Q3 25
$1.84
Q2 25
$1.34
Q1 25
$0.39
Q4 24
$1.16
$2.10
Q3 24
$4.42
$1.34
Q2 24
$-12.48
$1.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILMN
ILMN
SF
SF
Cash + ST InvestmentsLiquidity on hand
$1.2B
$2.3B
Total DebtLower is stronger
$617.4M
Stockholders' EquityBook value
$2.7B
$6.0B
Total Assets
$6.6B
$41.3B
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILMN
ILMN
SF
SF
Q1 26
$1.2B
Q4 25
$1.6B
$2.3B
Q3 25
$3.2B
Q2 25
$1.9B
Q1 25
$2.7B
Q4 24
$93.0M
$2.6B
Q3 24
$70.0M
$1.9B
Q2 24
$74.0M
$2.6B
Total Debt
ILMN
ILMN
SF
SF
Q1 26
Q4 25
$617.4M
Q3 25
$617.2M
Q2 25
$617.0M
Q1 25
$616.8M
Q4 24
$616.6M
Q3 24
$616.4M
Q2 24
$1.1B
Stockholders' Equity
ILMN
ILMN
SF
SF
Q1 26
$2.7B
Q4 25
$2.7B
$6.0B
Q3 25
$5.8B
Q2 25
$5.6B
Q1 25
$5.5B
Q4 24
$2.4B
$5.7B
Q3 24
$2.1B
$5.6B
Q2 24
$1.4B
$5.4B
Total Assets
ILMN
ILMN
SF
SF
Q1 26
$6.6B
Q4 25
$6.6B
$41.3B
Q3 25
$41.7B
Q2 25
$39.9B
Q1 25
$40.4B
Q4 24
$6.3B
$39.9B
Q3 24
$6.0B
$38.9B
Q2 24
$6.1B
$37.8B
Debt / Equity
ILMN
ILMN
SF
SF
Q1 26
Q4 25
0.10×
Q3 25
0.11×
Q2 25
0.11×
Q1 25
0.11×
Q4 24
0.11×
Q3 24
0.11×
Q2 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILMN
ILMN
SF
SF
Operating Cash FlowLast quarter
$289.0M
$382.4M
Free Cash FlowOCF − Capex
$251.0M
$369.0M
FCF MarginFCF / Revenue
23.0%
32.7%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
2.16×
1.45×
TTM Free Cash FlowTrailing 4 quarters
$1.1B
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILMN
ILMN
SF
SF
Q1 26
$289.0M
Q4 25
$321.0M
$382.4M
Q3 25
$338.3M
Q2 25
$607.5M
Q1 25
$-211.2M
Q4 24
$364.0M
$694.6M
Q3 24
$316.0M
$198.3M
Q2 24
$80.0M
$207.2M
Free Cash Flow
ILMN
ILMN
SF
SF
Q1 26
$251.0M
Q4 25
$267.0M
$369.0M
Q3 25
$321.1M
Q2 25
$592.7M
Q1 25
$-227.8M
Q4 24
$335.0M
$677.2M
Q3 24
$284.0M
$185.6M
Q2 24
$49.0M
$173.3M
FCF Margin
ILMN
ILMN
SF
SF
Q1 26
23.0%
Q4 25
23.0%
32.7%
Q3 25
33.4%
Q2 25
70.6%
Q1 25
-27.0%
Q4 24
30.3%
73.9%
Q3 24
26.3%
22.9%
Q2 24
4.4%
21.7%
Capex Intensity
ILMN
ILMN
SF
SF
Q1 26
Q4 25
1.2%
Q3 25
1.8%
Q2 25
1.8%
Q1 25
2.0%
Q4 24
2.6%
1.9%
Q3 24
3.0%
1.6%
Q2 24
2.8%
4.2%
Cash Conversion
ILMN
ILMN
SF
SF
Q1 26
2.16×
Q4 25
0.96×
1.45×
Q3 25
1.60×
Q2 25
3.92×
Q1 25
-3.99×
Q4 24
1.96×
2.85×
Q3 24
0.45×
1.25×
Q2 24
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ILMN
ILMN

Product revenue$917.0M84%
Service and other revenue$174.0M16%

SF
SF

Segment breakdown not available.

Related Comparisons